Strong Revenue Trends And Better Prospects Make Penumbra Stock A Good Bet
- Tuesday, May 24, 2022, 7:25
- Market
- Add a comment
We think that Penumbra (NYSE: PEN), a medical devices company focused on interventional therapies, currently is a better pick compared to the Gap stock (NYSE: GPS), a specialty retailer selling casual apparel, accessories, and personal care products, despite it being the more expensive of the two…
About the Author
admin123 has written 23414 stories on this site.
